Loading...
  • HSCT
  • Therefore, HLA-matched unrelated HSCT, HLAmismatched related HSCT, and unrelated cord blood transplantation have been investigated. (go.jp)
  • One-antigen mismatched related HSCT can be performed without T-cell depletion, but the outcome has been somewhat inferior to HSCT from an HLA-matched sibling or HSCT from an HLA-allele-matched unrelated donor. (go.jp)
  • However, the appropriate choice of these strategies as well as the difference in HSCT outcome with cord blood transplantation has not been clarified. (go.jp)
  • lymphoma
  • The B-Cell Lymphoma Moon Shot is revolutionizing the conventional medical research approach to rapidly translate findings into patient treatment options and develop personalized therapeutic strategies. (mdanderson.org)
  • Follicular lymphoma, mantle cell lymphoma, lymphoplasmacytoid lymphoma or marginal zone lymphoma which has been previously treated with autologous or allogeneic stem cell transplantation. (mdanderson.org)
  • 2) Continued from #1:T-cell prolymphocytic leukemia, large granular lymphocyte leukemia, mycosis fungoides / Sezary syndrome or peripheral T-cell lymphoma which has been previously treated with at least one line of chemotherapy or monoclonal antibody therapy. (mdanderson.org)
  • healthy stem cells
  • In addition, the significance and the role of anergic NK cells will be discussed in induction of tumor resistance, as well as in shaping the size and differentiation of healthy stem cells. (jcancer.org)
  • Monoclonal
  • RATIONALE: Monoclonal antibodies, such as alemtuzumab, can find cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. (clinicaltrials.gov)